Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
165,547,872
-
Total 13F shares
-
30,025,605
-
Share change
-
+2,418,739
-
Total reported value
-
$634,386,631
-
Price per share
-
$21.11
-
Number of holders
-
118
-
Value change
-
+$55,521,976
-
Number of buys
-
74
-
Number of sells
-
36
Institutional Holders of CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) as of Q4 2017
As of 31 Dec 2017,
CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,025,605 shares.
The largest 10 holders included
FMR LLC, TRV GP, LLC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, Vanguard Group Inc, BVF INC/IL, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), and Numeric Investors LLC.
This page lists
118
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.